Abstract

Chronic Neuropathic Pain: Pharmacological Interventions in New Millennium

Author(s): Jones Marty

Issue: Jan/Feb 2000 - Compounding for Pain Management

Page(s): 6-15

Download in electronic PDF format for $75

Abstract

Recent reports of N-methyl-D-aspartate receptor antagonists, glutamate antagonists, alpha2-agonists, gamma-aminobutyric acid agonists, alpha1-antagonists, opioids and antioxidants in various combinations provide the contemporary rationale that is furnishing increased efficacy in the clinical management of chronic neuropathic pain, with fewer side effects. This article focuses on this new theory as an approach, from the perspective of a compounding pharmacist, to provide better control of chronic neuropathic pain in the new millennium. Implementation of this theory in daily practice within the triad of care will enhance the odds of positive outcomes in patients suffering from chronic neuropathic pain. The author focuses on pathophysiology, evidence, a new approach and clinical compounding success. He concludes that this is a huge market and that the efficacy is significant using the approach presented in this article.

Related Keywords

Related Categories

Printer-Friendly Version

Related Articles from IJPC

Issue/Page View/Buy	Title/Author (Click for Abstract / Details / Purchase)
Jan/Feb 2000 Pg. 6-15	Chronic Neuropathic Pain: Pharmacological Interventions in New Millennium Author(s): Jones Marty
May/Jun 2010 Pg. 182-192	Compounded Analgesic Therapy for Disorders of Movement: Arthritis, Neuropathic Pain, and Postpolio Syndrome Author(s): Brown Scott, Erickson Brian, Muller George, Bryant-Snure Susan J, Mestayer Richard F III
Jan/Feb 2002 Pg. 4-6	Clinical Nuggets and Pearls: Chronic Neuropathic Pain and Opioid Tolerance Author(s): Jones Marty
Mar/Apr 2000 Pg. 91-93	Transdermal Gels in the Treatment of Diabetic Neuropathy Author(s): Hodges Caroline J, Jones Thomas H, Willoughby David L
Jan/Feb 2003 Pg. 21-23	Profile of a Practice: Ward Drug Company Diabetic Shoppe and Prescription Compounding Center Author(s): Vail Jane
May/Jun 2010 Pg. 200-203	Topical Medications for Orofacial Neuropathic Pain Author(s): Bramwell Bethany L
May/Jun 2020 Pg. 182-186	Compounding Pearls -- Wound Care: Diabetic Foot Ulcers, Part 1 Author(s): Riepl Mike
Mar/Apr 2024 Pg. 100-109	Compounded Pain Formulations: What is the Evidence? Author(s): Asbill Scott, Sweitzer Sarah M, Spigener Shuler, Romero-Sandoval Alfonso
Jul/Aug 2014 Pg. 278-286	Compounded Pain Formulations: What is the Evidence? Author(s): Asbill Scott, Sweitzer Sarah M, Spigener Shuler, Romero-Sandoval Alfonso
May/Jun 2007 Pg. 202-211	Levorphanol for the Treatment of Severe Chronic Pain Author(s): McNulty Jack P
Jan/Feb 2022 Pg. 65-71	Physical Stability and Release Profile of Compounded Gabapentin Containing Pluronic Lecithin Organogel for Neuropathic Pain Management Author(s): Hong Eun Ji, Sumanasekera Wasana, Le Uyen Minh
Jul/Aug 2004 Pg. 265-267	Case Report: Wound Care of a Diabetic Foot Ulcer Author(s): Wynn Tom
Mar/Apr 2024 Pg. 135	Ketamine Hydrochloride 5%, Gabapentin 10%, Clonidine Hydrochloride 0.2%, and Baclofen 2% in Lipoderm Author(s): Allen Loyd V Jr
Mar/Apr 2006 Pg. 159-160	PostScription: Treatment of Chronic Pain with Methadone or Levorphanol Author(s): McNulty Jack P
May/Jun 2009 Pg. 182-190	Update on Managing Neuropathic Pain Author(s): McNulty Jack P, Muller George
May/Jun 2016 Pg. 231	Ketamine Hydrochloride 5%, Gabapentin 10%, Clonidine Hydrochloride 0.2%, and Baclofen 2% in Lipoderm Author(s): Allen Loyd V Jr
May/Jun 2010 Pg. 193-199	The Role of Sex Hormones on Fibromyalgia Pain Mediators Author(s): Bramwell Bethany L
Sep/Oct 2005 Pg. 339-346	Dextromethorphan, an NMDA receptor antagonist, as a Treatment for Pain Author(s): Mishkan Emilyn S
May/Jun 2004 Pg. 181-185	Compounding in the Pharmacy Curriculum: Beyond the Basics Author(s): Hinkle Amanda R, Newton Gail D
Mar/Apr 2000 Pg. 84-87	The Clinical Pharmacist's Role in Compounding for the Diabetic Patient Author(s): Harshbarger Robert, Harshbarger Diana